Tech Company Inital Public Offerings
Vor Biopharma IPO
Headquartered in Cambridge, Vor Biopharma is now a public company.
Transaction Overview
Company Name
Announced On
2/5/2021
Transaction Type
IPO
Amount
$150,000,000
Proceeds Purpose
Use of proceeds for the Vor Biopharma IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
215 1st St. 430
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Vor Biopharma is an immuno-oncology company developing novel therapies with broad potential for treating cancer. Vor is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Siddhartha Mukherjee
Chief Executive Officer
Robert Ang
Chief Financial Officer
Nathan Jorgensen
Chief Medical Officer
Christopher Slapak
Chief Technical Officer
Sadik Kassim
VP - General Counsel
Amy Mendel
VP - Human Resources
Tania Philipp
VP - R & D
Tirtha Chakraborty
VP - Regulatory Affairs
Robert Pietrusko
Browse more venture capital transactions:
Prev: 2/5/2021: Slync venture capital transaction
Next: 2/5/2021: Promenade venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs